Mizuho reiterates Sempra Energy stock rating after Oncor approval By Investing.com

Mizuho reiterated an Outperform rating and $104 price target on Sempra, implying about 11% upside from the $94.02 share price. Texas regulators approved Oncor’s settlement on a 9.75% allowed ROE, 43.5% equity ratio, and a $560 million rate increase, while Sempra also completed $800 million of 5.250% notes due 2036 and SDG&E closed a $1.1 billion bond offering. The developments are constructive for Sempra’s financing and regulated utility outlook, but the article remains largely a routine update with limited immediate price impact.

Analysis

The near-term setup is more about balance-sheet de-risking than operating surprise. A regulated settlement with constructive equity treatment should lower perceived earnings volatility, which matters because Sempra has been trading more like a hybrid utility/LNG capital allocator than a classic defensive name; that usually compresses the required equity risk premium if execution stays clean. The bond market take-away is even more important: multiple successful offerings at different maturities suggest management is proactively terming out funding before the market assigns a higher spread for project and political optionality.

The second-order winner is likely the entire capital program, not just Oncor. Better visibility on allowed returns improves the internal hurdle rate for the Texas network and should support incremental rate-base investment, while also reducing the probability that future LNG or infrastructure spending gets forced into a punitive financing window. The flip side is that stronger access to debt may tempt investors to underappreciate execution risk in the non-utility portfolio; if LNG timing slips or transaction milestones move right, the market can quickly reprice this back toward a pure-duration utility with less upside.

The key contrarian point is that this may already be priced as a “clean story” despite still carrying multiple event risks over the next 1-2 quarters. The stock can rerate on continued de-risking, but the upside likely requires a better-than-expected cadence on asset monetizations and project milestones, not just regulatory approval. If rates back up, the leverage to equity valuation is negative because the name’s appeal is partly anchored in long-duration cash flows and financing confidence rather than near-term earnings acceleration.

Key Decisions for Investors

• Long SREA on a pullback of 2-3%: target 6-8% upside over 1-2 months if financing/regulatory clarity keeps tightening; use a 4% stop if rates or spread sentiment reverses.
• Pair trade: long SREA / short a higher-beta infrastructure levered name with similar duration exposure if the market starts rewarding de-risked balance sheets over project optionality; aim for 3-5% relative outperformance over 6-8 weeks.
• If you want convexity, buy near-dated SREA calls into the early-May update window: the setup is a classic event-driven rerating, but size modestly because disappointment on transaction timing can erase the premium quickly.
• Add SDGE/Sempra credit exposure selectively on spread tightening: the bond issuance indicates demand is there, and the best risk/reward may be in subordinated utility credit rather than the equity if rates stay stable.
• Avoid chasing strength above recent highs; the asymmetry is better on a pullback, because the next leg higher needs concrete milestones, not just approval headlines.